Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (841-850 of 1,834) with videos related to

Pageof 184
Sort By:
Mabs|February 9, 2024
Electrostatic properties of human germlines and biodistribution of small biologicsLeticia Maria De Souza Cordeiro, Kelley Christine Atkinson, Argin Aivazian, et al.
Mabs|January 19, 2024
Interactions of the anti-FcRn monoclonal antibody, rozanolixizumab, with Fcγ receptors and functional impact on immune cells <i>in vitro</i>Omar S Qureshi, Emma J Sutton, Rosemary F Bithell, et al.
Mabs|October 4, 2024
A comparative study of the developability of full-length antibodies, fragments, and bispecific formats reveals higher stability risks for engineered constructsItzel Condado-Morales, Fabian Dingfelder, Isabel Waibel, et al.
Mabs|September 26, 2024
FcRn-enhancing mutations lead to increased and prolonged levels of the HIV CCR5-blocking monoclonal antibody leronlimab in the fetuses and newborns of pregnant rhesus macaquesJoanna Zikos, Gabriela M Webb, Helen L Wu, et al.
Mabs|August 8, 2024
Discovery of a novel highly specific, fully human PSCA antibody and its application as an antibody-drug conjugate in prostate cancerXiaojie Chu, Seungmin Shin, Du-San Baek, et al.
Mabs|May 14, 2025
Development of potent humanized TNFα inhibitory nanobodies for therapeutic applications in TNFα-mediated diseasesTao Yin, Aubin Ramon, Matthew Greenig, et al.
Mabs|May 5, 2025
Homogeneous antibody-drug conjugates with dual payloads: potential, methods and considerationsMiao Wen, Abigail Yu, Young Park, et al.
Mabs|March 25, 2025
Prediction of human pharmacokinetics of Fc-engineered therapeutic monoclonal antibodies using human FcRn transgenic miceKenta Haraya, Takuya Ichikawa, Naoaki Murao, et al.
Mabs|March 24, 2025
Design of orthogonal constant domain interfaces to aid proper heavy/light chain pairing of bispecific antibodiesKyle A Barlow, Michael B Battles, Michael E Brown, et al.
Mabs|March 5, 2025
PROPERMAB: an integrative framework for <i>in silico</i> prediction of antibody developability using machine learningBian Li, Shukun Luo, Wenhua Wang, et al.
Pageof 184

Showing results (841-850 of 1,834) with videos related to

Sort By:
Pageof 184
Mabs|February 9, 2024
Electrostatic properties of human germlines and biodistribution of small biologicsLeticia Maria De Souza Cordeiro, Kelley Christine Atkinson, Argin Aivazian, et al.
Mabs|January 19, 2024
Interactions of the anti-FcRn monoclonal antibody, rozanolixizumab, with Fcγ receptors and functional impact on immune cells <i>in vitro</i>Omar S Qureshi, Emma J Sutton, Rosemary F Bithell, et al.
Mabs|October 4, 2024
A comparative study of the developability of full-length antibodies, fragments, and bispecific formats reveals higher stability risks for engineered constructsItzel Condado-Morales, Fabian Dingfelder, Isabel Waibel, et al.
Mabs|September 26, 2024
FcRn-enhancing mutations lead to increased and prolonged levels of the HIV CCR5-blocking monoclonal antibody leronlimab in the fetuses and newborns of pregnant rhesus macaquesJoanna Zikos, Gabriela M Webb, Helen L Wu, et al.
Mabs|August 8, 2024
Discovery of a novel highly specific, fully human PSCA antibody and its application as an antibody-drug conjugate in prostate cancerXiaojie Chu, Seungmin Shin, Du-San Baek, et al.
Mabs|May 14, 2025
Development of potent humanized TNFα inhibitory nanobodies for therapeutic applications in TNFα-mediated diseasesTao Yin, Aubin Ramon, Matthew Greenig, et al.
Mabs|May 5, 2025
Homogeneous antibody-drug conjugates with dual payloads: potential, methods and considerationsMiao Wen, Abigail Yu, Young Park, et al.
Mabs|March 25, 2025
Prediction of human pharmacokinetics of Fc-engineered therapeutic monoclonal antibodies using human FcRn transgenic miceKenta Haraya, Takuya Ichikawa, Naoaki Murao, et al.
Mabs|March 24, 2025
Design of orthogonal constant domain interfaces to aid proper heavy/light chain pairing of bispecific antibodiesKyle A Barlow, Michael B Battles, Michael E Brown, et al.
Mabs|March 5, 2025
PROPERMAB: an integrative framework for <i>in silico</i> prediction of antibody developability using machine learningBian Li, Shukun Luo, Wenhua Wang, et al.
Pageof 184